Introduction
Gastric cancer associated with peritoneal carcinomatosis is a frequent cause of cancer-related death worldwide 1, 2 . Presently, there is no effective therapy and the five-year survival rate is less than 2% 3 .
Previously we studied the features that enable gastric tumors to develop peritoneal dissemination.
Comparative microarray analyses were performed using human specimens from consecutive gastric cancer patients with peritoneal carcinomatosis versus gastric cancer patients without peritoneal carcinomatosis. Tissues recovered from individuals with peritoneal dissemination demonstrated significantly higher mRNA levels of phosphoglycerate kinase 1 (PGK1), the chemokine receptor 4 (CXCR4), its ligand chemokine ligand 12 (CXCL12) and β-catenin 4 . PGK1 is an ATP-generating enzyme of the glycolytic pathway that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. In the nucleus, PGK1 affects DNA replication and repair 5 . It is assumed that the glycolytic pathway and glycolysis-related genes play an important role in tumorigenesis.
Solid tumor cells employ glycolytic enzymes, such as PGK1, to generate ATP when their supply of oxygen is limited 6 . Further, PGK1 is involved in the onset of malignancies, such as prostate, breast, pancreatic, multi-drug resistant ovarian cancer and as recently reported, also in gastric cancer 4, 5, [7] [8] [9] .
The human chemokine system contains about 50 known ligands and 20 G protein-coupled receptors.
Chemokines and their receptors play important roles in migration and activation of leukocytes, angiogenesis and tumor growth 10 . CXCR4, a seven-transmembrane G-protein-coupled chemokine receptor and its ligand CXCL12 also known as stromal-derived-factor-1 (SDF1) promote the progression and spreading of a number of malignant diseases including prostate, non-small-cell lung, pancreatic, breast and gastric cancer 2, 4, [11] [12] [13] [14] . CXCR4 is expressed on hematopoietic and epithelial cancer cells, where it may aid in establishing metastasis along a chemotactic gradient to organs expressing CXCL12 15, 16 . Moreover, CXCL12-expressing cancer cells may protect themselves from cytotoxic immune responses via induction of apoptosis in cytotoxic T cells and inducing a local Th1→Th2 shift in the tumor area [16] [17] [18] . β-catenin, a 92-kDa protein, plays a central role in cadherinbased cell adhesion processes, as a downstream effector in the Wnt-signaling pathway, and also as a potential downstream target of PGK1 5, 19 . In gastric cancer, increased expression of β-catenin is associated with enhanced proliferation, invasiveness, metastasis, angiogenesis and drug resistance 4, 20, 21 . There is a close relationship between the regulation of the CXCR4/CXCL12 axis, β-catenin and PGK1 in prostate cancer 5 . Interestingly, as already mentioned above, we detected a strong overexpression of these genes in human primary gastric cancer associated with development of peritoneal carcinomatosis. Therefore we studied the relationship between peritoneal dissemination through PGK1 and the regulation within its signaling targets CXCR4, CXCL12 and β-catenin. Here, we
report that PGK1 appears to be a crucial enzyme for peritoneal dissemination of gastric cancer in both CXCR4/CXCL12-dependent and by CXCR4/CXCL12-independent mechanisms.
Materials and Methods
Cell culture. Sequence specific primers were used as follows: the cells before seeding them in the top chamber was used to inhibit cell invasion. Each assay was performed using at least four replicates.
Cell-viability assay
Transfection was performed using 2x10 6 
Results

PGK1 regulates CXCR4 and β-catenin expression
To detect that the CXCR4/CXCL12 axis and β-catenin are regulated by PGK1 expression, quantitative real time-PCR (qRT-PCR), flow cytometry and western blots were performed after siRNA targeting of PGK1 in MKN45 gastric adenocarcinoma cells. QRT-PCR revealed a considerable down-regulation of PGK1, CXCR4 and β-catenin expression (Fig. 1A) . CXCL12 mRNA was not detectable in the MKN45 cell line. Western blot analysis was conducted for PGK1 and flow cytometry for CXCR4 and β-catenin with the objective to confirm the mRNA expression data. Western blot showed a considerable down regulation of PGK1 expression in siPGK1-treated cells compared to control cells using β-actin as a reference (Fig. 1C) . β-catenin and CXCR4 protein expression were decreased in MKN45 siPGK1 cells (Fig. 1F) . The distinct time intervals can be explained by the fact that the effects detected on mRNA levels are translated with a certain delay into effects on protein levels. Hence, the most pronounced effects on protein levels were observed at later points of time.
PGK1 and CXCR4 regulate their expression reciprocally
To determine whether the inhibition of CXCR4 regulates PGK1 expression, siRNA was used to decrease CXCR4 expression. Inhibition of CXCR4 reduced both, mRNA expression of PGK1 (Fig.1B) and PGK1 protein levels (Fig.1D) , suggesting that reciprocal regulation exists between PGK1 and CXCR4.
Cell-viability assay
Overall proliferation and survival of the siPGK1-treated cells and the corresponding control siRNA treated cells were evaluated by the trypan blue assay over 4 days following transfection (Fig. 1E) . The number of viable and cells unable to exclude the dye in both groups were comparable (the transfected with PGK1 and siControl). This suggests that the knockdown of PGK1 is not responsible for relevant differences in cell death.
Overexpression of PGK1 regulates CXCR4 and β-catenin expression.
Since elevated PGK1 levels are a prominent feature of peritoneal dissemination in gastric cancer, CXCR4 and β-catenin expression ( Fig. 2A, right panel) . Western blot analysis revealed that overexpression of PGK1 in pEF-IRES cells was achieved using β-actin as a reference (Fig. 2B) . In these cells, significantly higher protein levels of CXCR4 and β-catenin were detected compared to the corresponding controls (Fig. 2C ). These data suggest that PGK1 is a regulatory molecule of CXCR4
and β-catenin.
Overexpression of PGK1 increases the invasiveness of gastric cancer in vitro.
To test the hypothesis that PGK1 overexpression promotes invasion, invasion assays were performed in which a basement membrane matrix (e.g. Matrigel™) was used as a barrier and NIH-3T3 conditioned medium with recombinant human CXCL12 was used as the chemoattractant. PGK1
MKN45/pEF-IRES cells invaded dramatically stronger than MKN45/control cells (Fig 3A) . To elucidate if the invasiveness of these cells was mainly caused by PGK1 or CXCR4, the assays were performed in the presence or absence of anti-CXCR4 specific blocking antibodies. Under these conditions, invasion was only moderately inhibited (Fig. 3B ).
Overexpression of PGK1 by immunohistochemistry in human diffuse gastric cancer.
To further explore PGK1 expression in gastric cancer, immunohistochemical staining of diffuse primary gastric cancer specimens from 10 patients was performed. Peritoneal carcinomatosis was histologically confirmed in 6 of the 10 patients at the time of surgery. Five of these patients with peritoneal carcinomatosis showed a medium to strong nuclear staining for PGK1, whereas cytoplasmic staining was less intense or absent. Only in one sample where peritoneal carcinomatosis was histologically confirmed, a weak staining in a very few cells was detected. In patients where no peritoneal carcinomatosis was histologically confirmed, all of the samples showed only a weak or no staining for PGK1 (Fig. 4) .
Discussion
In this investigation the relationship between tumorigenesis, glycolytic metabolism, and chemokine signaling was examined. Using siRNA targeting PGK1 in a gastric cancer cell line, we discovered that the expression of the chemokine receptor CXCR4 and the Wnt-pathway member β-catenin were linked to PGK1 expression. Flow cytometry confirmed the regulation of CXCR4 and β-catenin on protein level. Similarly, when CXCR4 was targeted by siRNA, PGK1 expression was diminished.
Hence, PGK1 and CXCR4 are able to regulate each other in a co-stimulating way. Likewise, assuming that elevated levels of PGK1 are crucial for peritoneal dissemination in gastric cancer, the effects of overexpression of PGK1 were further evaluated. PGK1 overexpression in gastric cancer cells resulted in significantly elevated mRNA expression and protein levels of CXCR4 and β-catenin. In vitro invasion assays underlined these findings showing that cells invaded more dramatically when PGK1 was overexpressed. Blocking CXCR4 in the invasion assay revealed only a moderate inhibition of invading cells. Performing immunohistochemical staining of diffuse human primary gastric cancer specimens, we further detected that patients with peritoneal dissemination showed a moderate to stronger staining compared to the primary tumors without peritoneal dissemination. These results lead to two conclusions:
First, there is a direct connection between PGK1 signaling and CXCR4 and β-catenin expression. . A second mechanism of cell proliferation, angiogenesis, tumor invasion and metastasis in gastric cancer is mediated through β-catenin 4, 20, 21 . A third and novel mechanism is supported by the PGK1 data. Our previous work showed that patients with gastric cancer developing peritoneal carcinomatosis, compared to patients without further dissemination, displayed much higher mRNA levels of CXCR4/CXCL12, β-catenin and the glycolytic enzyme PGK1 4 .
Our new data concerning PGK1 and its regulatory effects, even though based on protein levels rather than activity per se, provide comprehensive evidence of the "Warburg effect". In the 1950s Warburg quantified the impaired mitochondrial function and increased dependence on glycolysis as a source of energy, using ascitic cancer cells PGK1 is known to be involved in the onset of several malignancies, such as breast, pancreatic and ovarian cancer [7] [8] [9] . A significant association between PGK1 expression and the CXCR4/CXCL12 axis was recently reported in prostate cancer cell lines, where overexpression of PGK1 increased the metastatic rate 5 . One of our most striking findings was that PGK1 seems to be a central molecule concerning tumor invasion and metastasis in gastric cancer (Fig. 5) . Overexpression of PGK1 resulted in significantly elevated expression and protein levels of CXCR4 and β-catenin and enhanced invasiveness in Matrigel™ assays. High levels of CXCL12, via CXCR4 overexpression, might protect cancer cells (as already described) from immune responses and elevated CXCR4 levels multiplying the metastatic process 15 . On the other hand, there is evidence, that low levels of extracellular CXCL12 may augment metastatic potential towards environments with higher levels of CXCL12 16 .
Since PGK1 was shown to regulate β-catenin in prostate cancer, it is possible that an enhanced expression of PGK1 is able to decrease cancer cell-cell-adhesion linked to Wnt signaling and thus increase cell migration 5 . Those results previously obtained are underlined by our recent findings in human gastric cancer patients 4 . In summary, the results presented here show that high levels of PGK1 are essential for tumor growth and metastasis. These data further show a direct relationship between PGK1 signaling CXCR4 and β-catenin expression and represent a promising pathway concerning peritoneal carcinomatosis and metastasis in gastric cancer. These findings support the comprehension between glucose metabolism and chemokine function and might serve as potential therapeutic targets to prevent metastasis of gastric carcinoma cells.
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The authors declare no conflict of interest or conflicting financial interests. signaling. PGK 1 overexpression leads to increased CXCR4/CXCL12 signaling which supports metastatic homing and tumor dissemination. Enhanced PGK1 expression influences tumor invasion by elevated CXCR4 and β-catenin levels. CXCR4 is reciprocally regulated by PGK1 and overexpression of CXCR4 allows a link to CXCL12 signaling and thus immune evasion mechanisms apart from direct influences. β-catenin furthermore exhibits its function in cell proliferation and metastasis. Therefore PGK1 might be a crucial enzyme in peritoneal dissemination and metastasis.
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